GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
Cross River gets $18 million USAID grant on SMGL
The ‘Saving Mothers, Giving Life’ (SMGL) Initiative concluded a productive week-long, global team-building meeting in Calabar with a five-year, $18 million grant from the United States Agency for International Development (USAID)
‘OneWellness’ health tracker platform launched in Nigeria
Targets 250, 000 users by 2024 OneHealth, an online pharmacy and healthcare platform has formally launched its OneWellness, a platform that provides healthcare management through access, adherence and accountability, in
Osinbajo extols nurses, midwives roles in health care services
• Pledges engagement of more nurses, midwives in revitalized PH ABUJA – Acting President, Prof Yemi Osinbajo, has commended nurses and midwives over the “increasing” roles they play in managing
0 Comments
No Comments Yet!
You can be first to comment this post!